FDA To Tackle Tough Pre-, Post-Market Issues At 510(k) Workshop
This article was originally published in The Gray Sheet
Executive Summary
FDA's upcoming public meeting on strengthening the 510(k) review process will explore issues in four key areas: predicate devices; new technologies and scientific evidence; practices for managing the high volume of 510(k) submissions; and post-market surveillance